Arbutus Announces Departure of Chief Financial Officer; Appoints Interim CFO

0 Comments 1 view(s)

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 13, 2018 (GLOBE NEWSWIRE) —  Arbutus Biopharma Corporation (NASDAQ:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that Bruce Cousins, Executive Vice President and Chief Financial Officer, is leaving the Company but will remain available on a consulting basis. Koert VandenEnden, Arbutus’ Vice President of Finance, will serve as Interim Chief Financial Officer. The Company will …

Full story available on Benzinga.com